Choksi Laboratories Intrinsic Value
Choksi Laboratories (CHOKSILA) median intrinsic value is ₹48.55 from 9 valuation models (range ₹34–₹233), vs current price ₹112.80 — -57.0% downside (Trading Above Calculated Value), margin of safety -100.0%. For current market price and key ratios, visit CHOKSILA stock price BSE.
CHOKSILA Valuation Methods Summary — DCF, Graham Number & P/E
Choksi Laboratories intrinsic value across 9 models vs current price ₹112.80 — upside/downside and value range per method. Analyse CHOKSILA shareholder distribution to track promoter, FII and institutional holdings.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹33.84 | ₹27.07 - ₹40.61 | -70.0% | EPS: ₹2.82, Sector P/E: 12x |
| Book Value Method | asset | ₹37.14 | ₹33.43 - ₹40.85 | -67.1% | Book Value/Share: ₹37.14, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹52.57 | ₹47.31 - ₹57.83 | -53.4% | Revenue/Share: ₹65.71, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹102.86 | ₹92.57 - ₹113.15 | -8.8% | EBITDA: ₹12.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹232.86 | ₹186.29 - ₹279.43 | +106.4% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹45.12 | ₹40.61 - ₹49.63 | -60.0% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹33.84 | ₹30.46 - ₹37.22 | -70.0% | Revenue Growth: 11.3%, Adj P/E: 8.5x |
| ROE Based Valuation | profitability | ₹56.40 | ₹50.76 - ₹62.04 | -50.0% | ROE: 7.7%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹48.55 | ₹43.70 - ₹53.41 | -57.0% | EPS: ₹2.82, BVPS: ₹37.14 |
CHOKSILA Intrinsic Value vs Market Price — All Valuation Models
Choksi Laboratories fair value range ₹34–₹233 vs current market price ₹112.80 across 9 valuation models. Read CHOKSILA dividend payout details for the complete payout history and dividend yield track record.
CHOKSILA Intrinsic Value Analysis — Undervalued or Overvalued?
Choksi Laboratories median intrinsic value ₹48.55, current price ₹112.80 — Trading Above Calculated Value by 57.0%, margin of safety -100.0%.
What is the intrinsic value of CHOKSILA?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Choksi Laboratories (CHOKSILA) is ₹48.55 (median value). With the current market price of ₹112.80, this represents a -57.0% variance from our estimated fair value.
The valuation range spans from ₹33.84 to ₹232.86, indicating ₹33.84 - ₹232.86.
Is CHOKSILA undervalued or overvalued?
Based on our multi-method analysis, Choksi Laboratories (CHOKSILA) appears to be trading above calculated value by approximately 57.0%.
CHOKSILA Financial Health — Key Ratios vs Industry Benchmarks
Choksi Laboratories financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.83 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 7.7% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 26.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.64x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
CHOKSILA Cash Flow Quality — Operating & Free Cash Flow
Choksi Laboratories operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹12 Cr | ₹8 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹12 Cr | ₹9 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹8 Cr | ₹8 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹8 Cr | ₹7 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹6 Cr | ₹2 Cr | Positive Free Cash Flow | 7/10 |